Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: A cross-sectional study

Journal of Alzheimer's Disease

Volumn 42, Issue 4, 2014, Pages 1337-1346

  García Casares, Natalia ^a   Jorge, Ricardo E ^b   García Arnés, Juan A ^c   Acion, Laura ^d   Berthier, Marcelo L ^a   Gonzalez Alegre, Pedro ^e   Nabrozidis, Alejandro ^a   Gutiérrez, Antonio ^a   Ariza, María José ^a   Rioja, Jose ^a   González Santos, Pedro ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Cognition; dementia; magnetic resonance imaging; mild cognitive impairment; neuropsychology; positron emission tomography; type 2 diabetes mellitus

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; ALLELE; ARTICLE; ATTENTION; BRAIN FUNCTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETIC PATIENT; DISEASE SEVERITY; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; FRAMINGHAM RISK SCORE; GENDER; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GRAY MATTER; HAMILTON SCALE; HUMAN; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; SEMANTICS; STROOP TEST; TASK PERFORMANCE; TEMPORAL LOBE; UNCUS; VERBAL MEMORY; VOXEL BASED MORPHOMETRY; WECHSLER MEMORY SCALE; AGED; BRAIN; DIAGNOSTIC USE; IMAGE PROCESSING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; SCINTISCANNING;

AGED; BRAIN; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84908014210     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140702     Document Type: Article

References (41)

1. Van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kap-pelle LJ, Biessels (2010) A4year follow-up studyofcognitive functioning in patients with type 2 diabetes mellitus. Dia-betologia 53, 58-65.
2. Nooyens AC, Baan CA, Spijkerman AM, Verschuren WM (2010) Type 2 diabetes and cognitive decline in middle-aged men and women: The Doetinchem Cohort Study. Diabetes Care 33, 1964-1969.
3. Kumari M, Marmot M (2005) Diabetes and cognitive function ina middle-aged cohort. Findings from the Whitehall II study. Neurology 65, 1597-1603.
4. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5, 64-74.
5. Qiu C, Sigurdsson S, Zhang Q, Jonsdottir MK, Kjartansson O, Eiriksdottir G, Garcia ME, Harris TB, Vanbuchem MA, Gudnason V, Launer LJ (2014) Diabetes, markers of brain pathology, and cognitive cognition: The AGES-Reykjavik study. Ann Neurol 75, 138-146.
6. Mehrabian S, Raycheva M, Gateva A, Todorova G, Angelova P, Traykova M, Stankova T, Kamenov Z, Traykov L (2012) Cognitive dysfunction profile and arterial stiffness in type 2 diabetes. J Neurol Sci 322, 152-156.
7. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koud-staal PJ, Hofman A, Breteler MM (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46, 1604-1610.
8. van Elderen SG, de Roos A, de Craen AJ, Westendorp RG, Blauw GJ, Jukema JW, Bollen EL, Middelkoop HA, van Buchem MA, van der Grond J (2010) Progression of brain atrophy and cognitive decline in diabetes mellitus: A 3-year follow-up. Neurology 75, 997-1002.
9. Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H (2006) Cognitive dysfunction associates with white matter hyper-intensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 22, 376-384.
10. Schmidt R, Launer LJ, Nilsson LG, Pajak A, Sans S, Berger K, Breteler MM, de Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Hofman A (2004) CASCADE Consortium. Magnetic resonance imaging of the brain in diabetes: The Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 53, 687-692.
11. Reijmer YD, Leemans A, Brundel M, Kappelle LJ, Bies-sels GJ, Utrecht Vascular Cognitive Impairment Study Group (2013) Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 62, 2112-2115.
12. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68, 51-57.
13. Garćia-Casares N, Berthier ML, Jorge RE, Gonzalez-Alegre P, Gutierrez Cardo A, Rioja Villodres J, Acione L, Ariza Corbo MJ, Nabrozidis A, Garćia-Arnés JA, González-Santos P (2014) Structural and functional brain changes in middle-aged type 2 diabetic patients: A cross-sectional study. J Alzheimers Dis 40, 375-386.
14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
15. Hindmarch I, Lehfeld H, De Jong P, Erzigkeit H (1998) The Bayer Activities of Daily Living Scale (B-ADL). Dement Geristr Cogn Disord 9, 20-26.
16. Olfield RC (1971) The assessment and analysis of handed-ness: The Edinburgh inventory. Neuropsychologia 9, 97-113.
17. Wilson PW, D'Agostino RB, Levy D (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847.
18. Tietz NW (1991) Clinical Guide to Laboratory Tests, 2nd edition, Saunders Co.
19. Koch W, Enrenhaft A, Griesser K, Pfeufer A, Müller J, Schömig A, Kastrati A (2002) TaqMan systems for geno-typing of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med 40, 1123-1131.
20. Smith A (1973) Symbol Digit Modalities Test, Manual. Western Psychological Services, Los Angeles.
21. Osterrieth PA (1944) Le test de copie d'une figure complexe. Arch Psychol 30, 206-356.
22. Wechsler D (2004) Escala de memoria de Wechsler-III (WMS-III), 3rd edition, TEA Ediciones, Madrid.
23. Partington J, Leiter R (1949) Partington's Pathways Test. Psy-chol Serv Center Bull 1, 11-20.
24. Stroop JR (1935) Studies of interference in serial verbal reaction. J Exp Psychol 18, 643-662.
25. Strauss E, Sherman EMS, Spreen O (2006) A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd editon, Oxford University Press, New York, pp.
26. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23, 56-62.
27. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38, 95-113.
28. Ashburner J, Friston KJ (2000) Voxel-based morpho metry-the methods. Neuroimage 11, 805-821.
29. Rousset OG, Ma Y, Evans AC (1998) Correction for partial volume effects in PET: Principle and validation. J Nucl Med 39, 904-911.
30. Talairach J, Tournoux P (1988) Co-planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System-an Approach to Cerebral Imaging, Thieme Medical Publishers, New York.
31. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A (2009) Modifiers of cognitive function and brain structure in middleaged and elderly individuals with type 2 diabetes mellitus. Brain 1280, 186-194.
32. van Eersel ME, Joosten H, Gansevoort RT, Dullaart RP, Slaets JP, Izaks GJ (2013) The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS One 8, e82991.
33. de la Monte SM (2014) Relationships between diabetes and cognitive impairment. Endocrinol Metab Clin North Am 43, 245-267.
34. Cui X, Abduljalil A, Manor BD, Peng CK, Novak V (2014) Multi-scale glycemic variability: A link to GM atrophy and cognitive decline in type 2 diabetes. PLoS One 9, e86284.
35. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ (2009) Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 32, 221-226.
36. Kuczynski B, Jagust W, Chui HC, Reed B (2009) An inverse association of cardiovascular risk and frontal lobe glucose metabolism. Neurology 72, 738-743.
37. Kumar A, Haroon E, Darwin C (2008) GM prefrontal changes in type 2 diabetes detected using MRI. J Magn Reson Imaging 27, 14-19.
38. Sullivan MD, Katon WJ, Lovato LC, Miller ME, Murray AM, Horowitz KR, Bryan RN, Gerstein HC, Marcovina S, Akpunonu BE, Johnson J, Yale JF, Williamson J, Launer LJ (2013) Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND Trial. JAMA Psychiatry 70, 1041-1047.
39. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ (2006) Brain magnetic resonanceimaging correlatesofimpaired cognitioninpatients with type 2 diabetes. Diabetes 55, 1106-1113.
40. Gluck ME, Ziker C, Schwegler M, Thearle M, Votruba SB, Krakoff J (Behav) (2013) Impaired glucose regulation is associated with poorer performance on the Stroop Task. Physiol 122, 113-119.
41. Zhang Y, Zhang X, Zhang J, Liu C, Yuan Q, Yin X, Wei L, Cui J, Tao R, Wei P, Wang J (2014) GM volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment. Neurosci Lett 562, 1-6.